What's breaking now, across thousands of outlets.
One offers concentrated exposure to 29 pharma giants with lower volatility, while the other provides broader diversification across 251 biotech companies at a cheaper cost.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This single data point is also crucial to the company's long-term investment thesis.
Your day-ahead look for Aug. 19, 2026
On today's show we discuss one of the greatest bull markets of all-time, falling valuations, why young people gamble, financial nihilism, the next recession, $3 trillion in money markets, when bond…
Digitale Vermögensverwalter erzielten 2025 teils zweistellige Renditen, wie eine neue Auswertung zeigt. Die Lösungen eignen sich besonders für zwei Anlegertypen.
